Efficacy and safety of a novel, nebulized glycopyrrolate for the treatment of COPD: effect of baseline disease severity and age; pooled analysis of GOLDEN 3 and GOLDEN 4

by Ohar J, Tosiello R, Goodin T, Sanjar S
Published 2018-12-01

Effect of background long-acting beta2-agonist therapy on the efficacy and safety of a novel, nebulized glycopyrrolate in subjects with moderate-to-very-severe COPD

by Kerwin EM, Tosiello R, Price B, Sanjar S, Goodin T
Published 2018-09-01